Search for: "In re: Genetically Modified Rice Litigation" Results 1 - 18 of 18
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jul 2011, 9:59 am by Joe Tort
The case was In Re: Genetically Modified Rice Litigation, E.D. [read post]
20 Nov 2008, 10:47 am
In re Genetically Modified Rice Litigation, MDL No.1811. [read post]
26 Aug 2008, 10:38 am
In re Genetically Modified Rice Litigation, MDL No.1811, 2008 WL 3539879 (E.D. [read post]
1 Feb 2010, 9:15 pm by Lawrence Solum
Johanns and (In Re Genetically Modified Rice Litigation are strikingly similar. [read post]
1 Aug 2011, 10:00 am by webmaster
Despite the trial court’s denial of class certification, the threat of a successful appeal and a string of victories by individual plaintiffs have resulted in a comprehensive $750 million settlement in the massive In re Genetically Modified Rice Litigation, No. 06-md-1811 (E.D. [read post]
1 Aug 2011, 10:00 am by webmaster
Despite the trial court’s denial of class certification, the threat of a successful appeal and a string of victories by individual plaintiffs have resulted in a comprehensive $750 million settlement in the massive In re Genetically Modified Rice Litigation, No. 06-md-1811 (E.D. [read post]
15 Oct 2009, 9:28 am
In re: Genetically Modified Rice Litigation, No.4-md-1811 (E.D. [read post]
  Precedent The In re Syngenta Case is similar, but unrelated, to a group of Federal Court lawsuits over genetically modified rice that are consolidated into a single case: In re Genetically Modified Rice Litigation in the Eastern District of Missouri. [read post]
July 14, 2015). [2] In re: Genetically Modified Rice Litigation, Case No. 4:06 MD 1811-CDP. [read post]
1 Nov 2007, 7:21 am
As demonstrated in recent decisions affecting the preservation of ESI (In re Genetically Modified Rice Litig., 2007 WL 1655757 (E.D. [read post]
Background As discussed more thoroughly in past articles, Syngenta is facing legal complaints from thousands of plaintiffs across the country regarding its alleged premature commercialization of a genetically-modified (GM) corn trait. [read post]
21 Oct 2010, 6:24 am by David G. Badertscher
The plan, which would liquidate $7 billion with the bulk coming from a $6 billion settlement between WaMu, its owner JPMorgan Chase, and the FDIC among various creditors, is set to be voted on by WaMu's creditors on Nov. 15 -- two weeks after the independent examiner's report is due.Bayer Agrees to 'Watershed' Settlement in 7,000-Case Rice Crop Contamination LitigationThe American LawyerLast Friday, Bayer Crop Science finished the fourth day of a bellwether trial in the… [read post]
22 Feb 2008, 6:00 pm
), (Washington State Patent Law Blog), (The IP Factor), (IPBiz), (IP Spotlight), (IP Law360), (Innovationpartners), (IPBiz),US FTC files complaint against Cephalon alleging the company paid four generic drug manufacturers (Ranbaxy, Teva, Mylan and Barr) to delay entry as part of litigation settlements: (IP Law360), (IP Law360), (Spicy IP),GlobalGlobal - GeneralWhat is IP value all about? [read post]